Cerus Corporation (CERS)
NASDAQ: CERS · Real-Time Price · USD
1.245
-0.005 (-0.40%)
At close: May 23, 2025, 4:00 PM
1.250
+0.005 (0.40%)
After-hours: May 23, 2025, 4:00 PM EDT
Cerus Market Cap
Cerus has a market cap or net worth of $238.95 million as of May 23, 2025. Its market cap has decreased by -30.13% in one year.
Market Cap
238.95M
Enterprise Value
257.48M
1-Year Change
-30.13%
Ranking
Category
Stock Price
$1.25
Market Cap Chart
Since December 1, 1998, Cerus's market cap has increased from $155.40M to $238.95M, an increase of 53.76%. That is a compound annual growth rate of 1.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2025 | 239.00M | -16.43% |
| Dec 31, 2024 | 286.00M | -26.93% |
| Dec 29, 2023 | 391.40M | -39.56% |
| Dec 30, 2022 | 647.60M | -44.80% |
| Dec 31, 2021 | 1.17B | 1.43% |
| Dec 31, 2020 | 1.16B | 92.90% |
| Dec 31, 2019 | 599.60M | -12.84% |
| Dec 31, 2018 | 687.90M | 78.40% |
| Dec 29, 2017 | 385.60M | -14.33% |
| Dec 30, 2016 | 450.10M | -26.68% |
| Dec 31, 2015 | 613.90M | 25.70% |
| Dec 31, 2014 | 488.40M | 7.48% |
| Dec 31, 2013 | 454.40M | 159.21% |
| Dec 31, 2012 | 175.30M | 30.14% |
| Dec 30, 2011 | 134.70M | 36.89% |
| Dec 31, 2010 | 98.40M | 27.79% |
| Dec 31, 2009 | 77.00M | 237.72% |
| Dec 31, 2008 | 22.80M | -89.05% |
| Dec 31, 2007 | 208.30M | 27.79% |
| Dec 29, 2006 | 163.00M | -28.38% |
| Dec 30, 2005 | 227.60M | 247.48% |
| Dec 31, 2004 | 65.50M | -34.63% |
| Dec 31, 2003 | 100.20M | -70.69% |
| Dec 31, 2002 | 341.90M | -52.47% |
| Dec 31, 2001 | 719.30M | -31.92% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.42B |
| Johnson & Johnson | 367.12B |
| AbbVie | 323.61B |
| Novo Nordisk | 299.78B |
| UnitedHealth Group | 265.37B |
| Abbott Laboratories | 228.13B |
| Novartis AG | 219.95B |
| AstraZeneca | 215.99B |